Here are Credit Suisse's top 3 biotech picks

Home › Here are Credit Suisse's top 3 biotech picks

Celgene : Target $144. Implied upside 33% . "We believe that CELG looks cheap relative to its growth after reviewing current and pipeline products.

23.11	contactglove tundratracker
23.11
23.11	RUSSELUNO
23.11	C282 800yd IP54
23.11	X-FLY4 27.5
23.11	8
23.11	(1~40)
23.11	01DVDBOX
More »

je.st